Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Microchips in the Parmigiano and Other Ways Europeans Are Fighting Fake Food
Business

Microchips in the Parmigiano and Other Ways Europeans Are Fighting Fake Food

Parmesan producers are among those seeking ways to their protect billion-dollar markets. Source link

Apple, Amazon, Starbucks to Report in Packed Earnings Week
Business

Apple, Amazon, Starbucks to Report in Packed Earnings Week

Earnings reports also from Uber Technologies, Pfizer and Kraft Heinz are expected to shed light on how consumer spending is holding up amid rising interest

Big Pharma Bets Big on China
Business

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link

Moderna, Merck Show Progress Toward Cancer Vaccines
Business

Moderna, Merck Show Progress Toward Cancer Vaccines

An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link

Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

Prometheus Biosciences To Be Acquired By Merck

(RTTNews) – In a bid to strengthen its immunology pipeline, Merck (MRK) has agreed to acquire Prometheus Biosciences Inc. (RXDX) for $200.00 per share in

Merck in Late-Stage Talks to Acquire Prometheus Biosciences
Finances

Merck in Late-Stage Talks to Acquire Prometheus Biosciences

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the

Pfizer, Merck trim prices in China for Paxlovid, molnupiravir
Stock Market

Pfizer, Merck trim prices in China for Paxlovid, molnupiravir

© Reuters. FILE PHOTO: Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. REUTERS/Wolfgang

Regeneron, Sanofi Look for Billions From COPD Drug
Finances

Regeneron, Sanofi Look for Billions From COPD Drug

The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease. Source link